Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Nativis Voyager for Newly Diagnosed GBM
Not Applicable
Completed
- Conditions
- Glioblastoma Multiforme
- First Posted Date
- 2017-09-08
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Nativis, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT03276286
- Locations
- 🇺🇸
Center for Neurosciences, Tucson, Arizona, United States
🇺🇸California Cancer Care Associates, Encinitas, California, United States
🇺🇸John Wayne Cancer Institute @ Providence St Johns Health Center, Santa Monica, California, United States
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
Not Applicable
Completed
- Conditions
- Glioblastoma Multiforme
- First Posted Date
- 2015-07-23
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- Nativis, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT02507102
- Locations
- 🇦🇺
St. Vincent's Hospital Melbourne, Melbourne, Victoria, Australia
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Not Applicable
Completed
- Conditions
- Glioblastoma Multiforme
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Nativis, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT02296580
- Locations
- 🇺🇸
University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States
🇺🇸Center for Neurosciences, Tucson, Arizona, United States
🇺🇸cCARE - California Cancer Associates for Research & Excellence, Encinitas, California, United States
News
No news found